Processa Pharmaceuticals, Inc.
PCSA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,191 | $4,706 | $6,504 | $16,498 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | -$0 | $926 | $0 | $70 |
| Total Curr. Assets | $1,874 | $5,632 | $8,387 | $18,327 |
| Property Plant & Equip (Net) | $76 | $149 | $228 | $74 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $8,057 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,280 | $6 | $6 | $6 |
| Total NC Assets | $1,356 | $154 | $233 | $8,136 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,229 | $5,787 | $8,620 | $26,464 |
| Liabilities | – | – | – | – |
| Payables | $881 | $312 | $328 | $219 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $189 | $189 | $402 |
| Total Curr. Liab. | $1,533 | $731 | $999 | $971 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $67 | $151 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $74 | $151 | $229 | $78 |
| Total Liabilities | $1,533 | $797 | $1,149 | $978 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $2 | $2 |
| Retained Earnings | -$87,219 | -$75,369 | -$64,248 | -$36,823 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | -$0 | $0 | $0 | $0 |
| Total Equity | $1,696 | $4,989 | $7,471 | $25,485 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,229 | $5,787 | $8,620 | $26,464 |
| Net Debt | -$1,191 | -$4,706 | -$6,504 | -$16,498 |